Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) has earned an average rating of “Buy” from the eleven ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have given a buy recommendation and two have assigned a strong buy recommendation to the […]

Sensus Healthcare, Inc. (NASDAQ:SRTS – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have issued a buy recommendation on […]